03.12.2017 |
Raj K. Maturi, MD; Adam R. Glassman, MS; Danni Liu, MSPH; et al
Some eyes have persistent diabetic macular edema (DME) following anti–vascular endothelial growth factor (anti-VEGF) therapy for DME. Subsequently adding intravitreous corticosteroids to the treatment regimen might result in better outcomes than continued anti-VEGF therapy alone.
JAMA Ophthalmol. 2018;136(1):29-38. doi:10.1001/jamaophthalmol.2017.4914